• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART VALVE Back to Search Results
Model Number 3300TFX
Device Problems Fluid/Blood Leak (1250); Gradient Increase (1270); Inadequacy of Device Shape and/or Size (1583); Patient-Device Incompatibility (2682); Material Split, Cut or Torn (4008)
Patient Problem Heart Failure/Congestive Heart Failure (4446)
Event Date 02/05/2021
Event Type  Injury  
Manufacturer Narrative
Additional narratives: patient prosthesis mismatch (ppm) is present when the effective orifice area of the inserted prosthetic valve is too small in relation to body size.Its main hemodynamic consequence is to generate higher than expected gradients through a normally functioning prosthetic valve.Ppm has been shown to be associated with worse hemodynamic function, less regression of left ventricular hypertrophy, more cardiac events, and lower survival.The device was not returned for evaluation, as it was discarded.The root cause of this event cannot be conclusively determined.However, it is likely that patient related and/or procedural factors contributed to the event.
 
Event Description
It was learned via implant patient registry that a 21mm aortic valve was explanted and replaced with a 29mm valve after an implant duration of 4 years, 4 months due to patient prosthesis mismatch, severe stenosis, and moderate to severe regurgitation.Per medical records the patient presented with chf and underwent redo-avr and rectangular root enlargement with hemashield patch.Intra-op tee showed normal functioning bioprosthesis with no paravalvular leak.Post-op course was complicated by seizure-like activity and hypernatremia.Patient was discharged to sar on pod #21.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital and patient family members) and is not received in the form of a conventional "customer complaint." the information reported may or may not be related to the edwards device.
 
Event Description
It was learned via implant patient registry that a 21mm aortic valve was explanted and replaced with a 29mm valve after an implant duration of 4 years, 4 months due to patient prosthesis mismatch, severe stenosis, and moderate to severe regurgitation.Per medical records the patient presented with chf and underwent redo-avr and rectangular root enlargement with hemashield patch.Intra-op tee showed normal functioning bioprosthesis with no paravalvular leak.It is noted the 21mm aortic valve had 2 holes in the non-coronary cusp.Post-op course was complicated by seizure-like activity and hypernatremia.Patient was discharged to sar on pod #21.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital and patient family members) and is not received in the form of a conventional "customer complaint." the information reported may or may not be related to the edwards device.
 
Manufacturer Narrative
The device history record (dhr) was not reviewed as the reported event does not allege a malfunction that could be related to a manufacturing deficiency and/or one was not confirmed through investigation.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS
Type of Device
REPLACEMENT HEART VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
MDR Report Key11726816
MDR Text Key252261943
Report Number2015691-2021-02685
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
PMA/PMN Number
P860057/S04
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup
Report Date 06/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/21/2020
Device Model Number3300TFX
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received05/17/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age68 YR
-
-